Cargando…
Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen
BACKGROUND/AIMS: At our hemodialysis (HD) unit, we noted a drop in the treatment dose of erythropoietin-stimulating agents (ESAs) when the frequency of dose adjustment was reduced from weekly, where doses were withheld if hemoglobin was >130 g/l, to monthly, where doses were not withheld. The aim...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290861/ https://www.ncbi.nlm.nih.gov/pubmed/22470378 http://dx.doi.org/10.1159/000329889 |